CAR-T cell researchers optimistic about future of treating blood cancers
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
2
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
2
An important discovery has been made by Professor Hyug Moo Kwon and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Jaeseok Yang from Yonsei University. Their study sheds ...
Sep 12, 2023
0
11
Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of defense against pathogens, according to a small study. These changes may help explain why the disease can damage so many different ...
Aug 18, 2023
1
68
There is a lot of health buzz around the term "inflammation" right now. From new scientific discoveries to celebrities and social media influencers, it seems like everyone is talking about this important bodily process and ...
Aug 15, 2023
0
25
In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2.
Aug 1, 2023
0
66
Many existing treatments for inflammatory bowel disease, like Remicade and Humira, work by blocking inflammatory cytokines such as tumor necrosis factor (TNF) and interleukins IL-12 and IL-23, which are over-produced in autoimmune ...
Jul 28, 2023
0
1
A new research paper was published in Oncotarget, titled "The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells."
Jul 26, 2023
0
1
Despite intensive research since the pandemic began, much remains unknown about COVID-19, particularly why it can be so severe in some cases and relatively mild in others. Now, researchers from Japan have identified a genetic ...
Jul 25, 2023
0
36
Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update ...
Jul 21, 2023
0
1
The inflammatory response is indispensable for protective immunity, yet microbial pathogens often trigger an excessive response, a "cytokine storm," harmful to the host. Despite recent advances in our understanding of inflammatory ...
Jul 19, 2023
0
1